Microperimetric changes after photodynamic therapy for central serous chorioretinopathy

American Journal of Ophthalmology

Volumn 151, Issue 2, 2011, Pages

  Senturk, Fevzi ^a   Karacorlu, Murat ^a   Ozdemir, Hakan ^a   Karacorlu, Serra Arf ^a   Uysal, Omer ^b  

^a Istanbul Retina Institute Inc   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

VERTEPORFIN;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; COMPUTER PROGRAM; FEMALE; HEIDELBERG SCANNING LASER OPHTHALMOSCOPE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; MICROPERIMETRY; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA FOVEA; SCANNING LASER OPHTHALMOSCOPE; SENSITIVITY ANALYSIS; VISUAL ACUITY;

EID: 78751642388     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.08.019     Document Type: Article

References (24)

1. R.F. Spaide Central serous chorioretinopathy F.G. Holz, R.F. Spaide, Medical Retina 2004 Springer Verlag Berlin-Heidelberg 77 93
2. J.D.M. Gass Stereoscopic atlas of macular diseases: diagnosis and treatment 4th ed. 1997 Mosby St. Louis 52 70
3. R. Levine, A. Brucker, and F. Robinson Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography Ophthalmology 96 6 1989 854 859
4. F. Cardillo Piccolino, and L. Borgia Central serous chorioretinopathy and indocyanine green angiography Retina 14 3 1994 231 242
5. D.R. Guyer, L.A. Yannuzzi, J.S. Slakter, J.A. Sorenson, A. Ho, and D. Orlock Digital indocyanine green videoangiography of central serous chorioretinopahy Arch Ophthalmol 112 8 1994 1057 1062
6. L.A. Yannuzzi, J.S. Slakter, and N.E. Gross Indocyanine green angiography guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study Retina 23 3 2003 288 298
7. M. Taban, D.S. Boyer, E.L. Thomas, and M. Taban Chronic central serous chorioretinopathy: photodynamic therapy Am J Ophthalmol 137 6 2004 1073 1080
8. F. Cardillo Piccolino, C.M. Eandi, L. Ventre, R.C. Rigault de la Longrais, and F.M. Grignolo Photodynamic therapy for chronic central serous chorioretinopathy Retina 23 6 2003 752 763
9. W.M. Chan, D.S. Lam, T.Y. Lai, B.S. Tam, D.T. Liu, and C.K. Chan Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level Br J Ophthalmol 87 12 2003 1453 1458
10. M. Battaglia Parodi, S. Da Pozzo, and G. Ravalico Photodynamic therapy in chronic central serous chorioretinopathy Retina 23 2 2003 235 237
11. C. Canakis, C. Livir-Rallatos, and Z. Panayiotis Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy Am J Ophthalmol 136 4 2003 750 752
12. T.Y. Lai, W.M. Chan, H. Li, R.Y. Lai, D.T. Liu, and D.S. Lam Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study Br J Ophthalmol 90 7 2006 869 874
13. H. Ozdemir, S.A. Karacorlu, F. Senturk, M. Karacorlu, and O. Uysal Assessement of macular function by microperimetry in unilateral resolved central serous chorioretinopathy Eye 22 2 2008 204 208
14. H. Ozdemir, F. Senturk, M. Karacorlu, S. Arf Karacorlu, and O. Uysal Macular sensitivity in eyes with central serous chorioretinopathy Eur J Ophthalmol 18 5 2008 799 804
15. U.M. Schmidt-Erfurth, H. Elsner, N. Terai, A. Benecke, G. Dahmen, and S.M. Michels Effects of verteporfin therapy on central visual field function Ophthalmology 111 5 2004 931 939
16. E. Midena, S. Vujosevic, E. Convento, A. Manfre, F. Cavarzeran, and E. Pilotto Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration Br J Ophthalmol 91 11 2007 1499 1503
17. U. Schmidt-Erfurth, S. Michels, I. Barbazetto, and H. Laqua Photodynamic effects on choroidal neovascularization and physiological choroid Invest Ophthalmol Vis Sci 43 3 2002 830 841 (Pubitemid 34184504)
18. U. Schlotzer-Schrehardt, A. Viestenz, G.O. Naumann, H. Laqua, S. Michels, and U. Schmidt-Erfurth Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes Graefes Arch Clin Exp Ophthalmol 240 9 2002 748 757
19. W.M. Chan, T.Y. Lai, R.Y. Lai, E.W. Tang, D.T. Liu, and D.S. Lam Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study Retina 28 1 2008 85 93
20. M. Reibaldi, N. Cardascia, and A. Longo Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy : a nonrandomized clinical trial Am J Opthalmol 149 2 2010 307 315
21. M. Varano, V. Parisi, and M. Tedeschi Macular function after PDT in myopic maculopathy:psychophysical and electrophysiological evaluation Invest Ophthalmol Vis Sci 46 4 2005 1453 1462
22. M. Reibaldi, F. Boscia, and T. Avitabile Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy Eur J Ophthalmol 19 1 2009 154 158
23. Y. Kurashige, A. Otani, and M. Sasahara Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 146 4 2008 513 519
24. A.F. Cruess, G. Zlateva, A.M. Pleil, and B. Wirostko Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties Acta Ophthalmol 87 2 2009 118 132